title: Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy.
authors.forename: Mónica
authors.initials: M
authors.lastname: García-Álvarez
authors.forename: Juan
authors.initials: J
authors.lastname: Berenguer
authors.forename: Dariela
authors.initials: D
authors.lastname: Micheloud
authors.forename: María
authors.initials: M
authors.lastname: Guzmán-Fulgencio
authors.forename: Pilar
authors.initials: P
authors.lastname: Catalán
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: López
authors.forename: Jaime
authors.initials: J
authors.lastname: Cosín
authors.forename: Pilar
authors.initials: P
authors.lastname: Miralles
authors.forename: Ana
authors.initials: A
authors.lastname: Carrero-Gras
authors.forename: Salvador
authors.initials: S
authors.lastname: Resino
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications* / Q000821:virology; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000378:metabolism; D012189:Retrospective Studies; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D015415:Biomarkers; D016898:Interferon-alpha; D012254:Ribavirin